Mabion, a leading biotechnology company in Poland, has raised 51 million US dollars via a private placement funding round. The successful placement generated gross proceeds of 175 million zloty, with shares being sold at a price of 91 zloty each...
Mabion, a leading biotechnology company in Poland, has raised 51 million US dollars via a private placement funding round. The successful placement generated gross proceeds of 175 million zloty, with shares being sold at a price of 91 zloty each...
